Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
CONTRASTING OCULAR AND SYSTEMIC GRAFT-VERSUS-HOST DISEASE PROGRESSION: TEMPORAL SHIFTS IN IMMUNE RESPONSES
Author Affiliations & Notes
  • Jerry Bohlen
    University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Caitlyn Wandvik
    University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Arman Charkhabi
    University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Pooja Dharmendran
    University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Cassidy Reandeau
    University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Eswar Puppala
    University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Rakhee Kalari Kandy
    University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Xuefang Cao
    University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Sarah Sunshine
    University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Footnotes
    Commercial Relationships   Jerry Bohlen None; Caitlyn Wandvik None; Arman Charkhabi None; Pooja Dharmendran None; Cassidy Reandeau None; Eswar Puppala None; Rakhee Kalari Kandy None; Xuefang Cao None; Sarah Sunshine None
  • Footnotes
    Support  Cigarette Restitution Fund, and UMB ICTR/CTSA KL2 Mentored Career Development Award
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 2910. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jerry Bohlen, Caitlyn Wandvik, Arman Charkhabi, Pooja Dharmendran, Cassidy Reandeau, Eswar Puppala, Rakhee Kalari Kandy, Xuefang Cao, Sarah Sunshine; CONTRASTING OCULAR AND SYSTEMIC GRAFT-VERSUS-HOST DISEASE PROGRESSION: TEMPORAL SHIFTS IN IMMUNE RESPONSES. Invest. Ophthalmol. Vis. Sci. 2024;65(7):2910.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Graft-versus-host disease (GVHD) affects ~50% of post-hematopoietic stem cell transplant recipients. This study explores immune-mediated changes in ocular GVHD progression compared to systemic tissues, focusing on distinctive transcriptional changes, particularly in granzyme B (GZMB), TNF-α, and IFN-γ, as contributors to the unique pathogenesis of ocular GVHD.

Methods : This study used an HLA-matched GVHD mouse model with two groups: (1) T cell and B cell depleted (TBCD-BM) mice without splenocytes; and (2) TBCD-BM mice with splenocytes. Systemic and ocular GVHD severity scores were assessed on days 5, 12, 17, 28, and 37. Mice were sacrificed on days 15, 20, and 40 for ocular and systemic tissue collection. Quantitative PCR analyzed GZMB, TNF-α, and IFN-γ fold changes in the cornea and spleen of each group.

Results : On day 15, GZMB increased 40-fold in the cornea and 2-fold in the spleen (LFD: 1.3). TNF-α showed no significant change in the cornea and a five-fold increase in the spleen (LFD: 0.7). IFN-γ increased 40-fold in both the cornea and spleen (LFD: 0). On day 20, GZMB showed a 7-fold increase in the cornea and a 2000-fold increase in the spleen (LFD: 2.5). TNF-α increased 7-fold in the spleen for both control and GVHD groups, with no significant change in the cornea (LFD: 0.9). IFN-γ increased 20-fold in the cornea and 80-fold in the spleen (LFD: 0.6). On day 40, GZMB showed a 5-fold change in the cornea and a 10-fold change in the spleen (LFD: 0.3). TNF-α increased 17-fold in cornea for the control group only, while TNF-α decreased to near-negligible levels in the spleen (LFD: 1.3). IFN-γ showed a 20-fold change in the cornea and a 5-fold change in the spleen (LFD: 0.6).

Conclusions : Transcriptional analysis reveals mechanistic differences in systemic and ocular GVHD, with distinct gene expression patterns in the cornea (ocular) and spleen (systemic). Our results suggests that there is an early cytotoxic T cell response in both the cornea and spleen and the later time points show a more robust cytotoxic T cell response in the eye, consistent with chronic oGVHD. GZMB mediated apoptosis as a result of activated cytotoxic T cells is more significant in the eyes earlier than systemic GVHD but appears to play an important role throughout the development of both systemic and ocular GVHD.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×